Skip to main content
NCBI home page
Protein & Cell logoLink to Protein & Cell
. 2011 May 15;2(4):320–332. doi: 10.1007/s13238-011-1029-y

Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway

Lee Aun Tan 1, Andrew C Yang 3, Uday Kishore 5, Robert B Sim 1,✉
PMCID: PMC4875202  PMID: 21574022

Abstract

Proteins of the complement system are known to interact with many charged substances. We recently characterized binding of C1q and factor H to immobilized and liposomal anionic phospholipids. Factor H inhibited C1q binding to anionic phospholipids, suggesting a role for factor H in regulating activation of the complement classical pathway by anionic phospholipids. To extend this finding, we examined interactions of C1q and factor H with lipid A, a well-characterized activator of the classical pathway. We report that C1q and factor H both bind to immobilized lipid A, lipid A liposomes and intact Escherichia coli TG1. Factor H competes with C1q for binding to these targets. Furthermore, increasing the factor H: C1q molar ratio in serum diminished C4b fixation, indicating that factor H diminishes classical pathway activation. The recombinant forms of the Cterminal, globular heads of C1q A, B and C chains bound to lipid A and E. coli in a manner qualitatively similar to native C1q, confirming that C1q interacts with these targets via its globular head region. These observations reinforce our proposal that factor H has an additional complement regulatory role of down-regulating classical pathway activation in response to certain targets. This is distinct from its role as an alternative pathway down-regulator. We suggest that under physiological conditions, factor H may serve as a downregulator of bacterially-driven inflammatory responses, thereby fine-tuning and balancing the inflammatory response in infections with Gram-negative bacteria.

Keywords: complement, lipid A, bacteria, factor H, C1q

References

  1. Albertí S., Marqués G., Hernández-Allés S., Rubires X., Tomás J. M., Vivanco F., Benedí V.J. Interaction between complement subcomponent C1q and the Klebsiella pneumoniae porin OmpK36. Infect Immun. 1996;64:4719–4725. doi: 10.1128/iai.64.11.4719-4725.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arvieux J., Reboul A., Bensa J.C., Colomb M.G. Characterization of the C1q receptor on a human macrophage cell line, U937. Biochem J. 1984;218:547–555. doi: 10.1042/bj2180547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bone R.C. The pathogenesis of sepsis. Ann Intern Med. 1991;115:457–469. doi: 10.7326/0003-4819-115-6-457. [DOI] [PubMed] [Google Scholar]
  4. Bunse R., Heinz H.P. Interaction of the capsular polysaccharide of Haemophilus influenzae type B with C1q. Behring Inst Mitt. 1993;93:148–164. [PubMed] [Google Scholar]
  5. Clas F., Euteneuer B., Stemmer F., Loos M. Interaction of fluid phase C1/C1q and macrophage membrane-associated C1q with gram-negative bacteria. Behring Inst Mitt. 1989;84:236–254. [PubMed] [Google Scholar]
  6. Charlesworth J.A., Scott D.M., Pussell B.A., Peters D.K. Metabolism of human beta 1H: studies in man and experimental animals. Clin Exp Immunol. 1979;38:397–404. [PMC free article] [PubMed] [Google Scholar]
  7. Cooper N.R., Morrison D.C. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol. 1978;120:1862–1868. [PubMed] [Google Scholar]
  8. Díaz A., Ferreira A., Sim R.B. Complement evasion by Echinococcus granulosus: sequestration of host factor H in the hydatid cyst wall. J Immunol. 1997;158:3779–3786. [PubMed] [Google Scholar]
  9. Dillon S.P., D’souza A., Kurien B.T., Scofield R.H. Systemic lupus erythematosus and C1q: A quantitative ELISA for determining C1q levels in serum. Biotechnol J. 2009;4:1210–1214. doi: 10.1002/biot.200800273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dodds A.W., Sim R.B., Porter R.R., Kerr M.A. Activation of the first component of human complement (C1) by antibody-antigen aggregates. Biochem J. 1978;175:383–390. doi: 10.1042/bj1750383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Edey M., Strain L., Ward R., Ahmed S., Thomas T., Goodship T.H. Is complement factor H a susceptibility factor for IgA nephropathy? Mol Immunol. 2009;46:1405–1408. doi: 10.1016/j.molimm.2008.12.002. [DOI] [PubMed] [Google Scholar]
  12. Eisenschenk F.C., Houle J.J., Hoffmann E.M. Mechanism of serum resistance among Brucella abortus isolates. Vet Microbiol. 1999;68:235–244. doi: 10.1016/S0378-1135(99)00075-9. [DOI] [PubMed] [Google Scholar]
  13. Fearon D.T. Regulation by membrane sialic acid of 1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc Natl Acad Sci U S A. 1978;75:1971–1975. doi: 10.1073/pnas.75.4.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gaboriaud C., Juanhuix J., Gruez A., Lacroix M., Darnault C., Pignol D., Verger D., Fontecilla-Camps J.C., Arlaud G.J. The crystal structure of the globular head of complement protein C1q provides a basis for its versatile recognition properties. J Biol Chem. 2003;278:46974–46982. doi: 10.1074/jbc.M307764200. [DOI] [PubMed] [Google Scholar]
  15. Gulati S., Cox A., Lewis L.A., Michael F.S., Li J., Boden R., Ram S., Rice P.A. Enhanced factor H binding to sialylated Gonococci is restricted to the sialylated lacto-N-neotetraose lipooligosaccharide species: implications for serum resistance and evidence for a bifunctional lipooligosaccharide sialyltransferase in Gonococci. Infect Immun. 2005;73:7390–7397. doi: 10.1128/IAI.73.11.7390-7397.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Haas C.J., van Leeuwen E.M., van Bommel T., Verhoef J., van Kessel K.P., van Strijp J.A. Serum amyloid P component bound to gram-negative bacteria prevents lipopoly-saccharide-mediated classical pathway complement activation. Infect Immun. 2000;68:1753–1759. doi: 10.1128/IAI.68.4.1753-1759.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ingram G., Hakobyan S., Hirst C.L., Harris C.L., Pickersgill T.P., Cossburn M.D., Loveless S., Robertson N.P., Morgan B.P. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain. 2010;133:1602–1611. doi: 10.1093/brain/awq085. [DOI] [PubMed] [Google Scholar]
  18. Jack D.L., Turner M.W. Anti-microbial activities of mannose-binding lectin. Biochem Soc Trans. 2003;31:753–757. doi: 10.1042/bst0310753. [DOI] [PubMed] [Google Scholar]
  19. Joiner K.A., Schmetz M.A., Sanders M.E., Murray T.G., Hammer C. H., Dourmashkin R., Frank M.M. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci U S A. 1985;82:4808–4812. doi: 10.1073/pnas.82.14.4808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Joiner K.A., Grossman N., Schmetz M., Leive L. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol. 1986;136:710–715. [PubMed] [Google Scholar]
  21. Kishore U., Gupta S.K., Perdikoulis M.V., Kojouharova M.S., Urban B.C., Reid K.B.M. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains. J Immunol. 2003;171:812–820. doi: 10.4049/jimmunol.171.2.812. [DOI] [PubMed] [Google Scholar]
  22. Kishore U., Ghai R., Greenhough T.J., Shrive A.K., Bonifati D.M., Gadjeva M.G., Waters P., Kojouharova M.S., Chakraborty T., Agrawal A. Structural and functional anatomy of the globular domain of complement protein C1q. Immunol Lett. 2004;95:113–128. doi: 10.1016/j.imlet.2004.06.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kishore U., Gaboriaud C., Waters P., Shrive A.K., Greenhough T. J., Reid K.B.M., Sim R.B., Arlaud G.J. C1q and tumor necrosis factor superfamily: modularity and versatility. Trends Immunol. 2004;25:551–561. doi: 10.1016/j.it.2004.08.006. [DOI] [PubMed] [Google Scholar]
  24. Kojouharova M.S., Gadjeva M.G., Tsacheva I.G., Zlatarova A., Roumenina L.T., Tchorbadjieva M.I., Atanasov B.P., Waters P., Urban B.C., Sim R.B., et al. Mutational analyses of the recombinant globular regions of human C1q A, B, and C chains suggest an essential role for arginine and histidine residues in the C1q-IgG interaction. J Immunol. 2004;172:4351–4358. doi: 10.4049/jimmunol.172.7.4351. [DOI] [PubMed] [Google Scholar]
  25. Kraiczy P., Würzner R. Complement escape of human pathogenic bacteria by acquisition of complement regulators. Mol Immunol. 2006;43:31–44. doi: 10.1016/j.molimm.2005.06.016. [DOI] [PubMed] [Google Scholar]
  26. Kubens B.S., Nikolai S., Opferkuch W. A third mechanism of serum resistance in Escherichia coli. Zentralbl Bakteriol. 1989;271:222–230. doi: 10.1016/S0934-8840(89)80076-3. [DOI] [PubMed] [Google Scholar]
  27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  28. Latsch M., Stemmer F., Loos M. Purification and characterization of LPS-free porins isolated from Salmonella minnesota. FEMS Microbiol Lett. 1992;69:275–281. doi: 10.1111/j.1574-6968.1992.tb05166.x. [DOI] [PubMed] [Google Scholar]
  29. Loos M., Clas F. Antibody-independent killing of gram-negative bacteria via the classical pathway of complement. Immunol Lett. 1987;14:203–208. doi: 10.1016/0165-2478(87)90102-7. [DOI] [PubMed] [Google Scholar]
  30. Maruvada R., Blom A.M., Prasadarao N.V. Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology. 2008;124:265–276. doi: 10.1111/j.1365-2567.2007.02764.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. McAleer M.A., Sim R.B. The complement system. In: Sim R.B., editor. Activators and Inhibitors of Complement. Dordrecht, Netherlands: Kluwer; 1993. pp. 1–15. [Google Scholar]
  32. Meri S., Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci U S A. 1990;87:3982–3986. doi: 10.1073/pnas.87.10.3982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Merino S., Vilches S., Canals R., Ramirez S., Tomás J.M. A C1q-binding 40 kDa porin from Aeromonas salmonicida: cloning, sequencing, role in serum susceptibility and fish immunoprotection. Microb Pathog. 2005;38:227–237. doi: 10.1016/j.micpath.2005.02.006. [DOI] [PubMed] [Google Scholar]
  34. Morrison D.C., Kline L.F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS) J Immunol. 1977;118:362–368. [PubMed] [Google Scholar]
  35. New R.C.C. Preparation of liposomes. In: New R. C. C., editor. Liposomes — a practical approach. Oxford, U.K.: IRI Press; 1990. pp. 3–104. [Google Scholar]
  36. Reid K.B., Porter R.R. Subunit composition and structure of subcomponent C1q of the first component of human complement. Biochem J. 1976;155:19–23. doi: 10.1042/bj1550019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Rietschel E.T., Kirikae T., Schade F.U., Mamat U., Schmidt G., Loppnow H., Ulmer A.J., Zähringer U., Seydel U., Di Padova F., et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 1994;8:217–225. doi: 10.1096/fasebj.8.2.8119492. [DOI] [PubMed] [Google Scholar]
  38. Ripoche J., Day A.J., Harris T.J., Sim R.B. The complete amino acid sequence of human complement factor H. Biochem J. 1988;249:593–602. doi: 10.1042/bj2490593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Roumenina L.T., Rouseva M., Zlatarova A., Kolev M., Ghai R., Olova N., Gadjeva M., Agrawal A., Mantovani A., Bottazzi B., et al. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational analyses using recombinant globular regions of C1q A, B and C chains. Biochemistry. 2006;45:4093–4104. doi: 10.1021/bi052646f. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schneider M.C., Exley R.M., Chan H., Feavers I., Kang Y.H., Sim R.B., Tang C.M. Functional significance of factor H binding to Neisseria meningitidis. J Immunol. 2006;176:7566–7575. doi: 10.4049/jimmunol.176.12.7566. [DOI] [PubMed] [Google Scholar]
  41. Shang S.Q., Chen G.X., Shen J., Yu X.H., Wang K.Y. The binding of MBL to common bacteria in infectious diseases of children. J Zhejiang Univ Sci B. 2005;6:53–56. doi: 10.1631/jzus.2005.B0053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Sim R.B., Malhotra R. Interactions of carbohydrates and lectins with complement. Biochem Soc Trans. 1994;22:106–111. doi: 10.1042/bst0220106. [DOI] [PubMed] [Google Scholar]
  43. Sim E., Sim R.B. Enzymic assay of C3b receptor on intact cells and solubilized cells. Biochem J. 1983;210:567–576. doi: 10.1042/bj2100567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sim R.B., Day A.J., Moffatt B.E., Fontaine M. Complement factor I and cofactors in control of complement system convertase enzymes. Methods Enzymol. 1993;223:13–35. doi: 10.1016/0076-6879(93)23035-L. [DOI] [PubMed] [Google Scholar]
  45. Stewart J.C. Colorimetric determination of phospholipids with ammonium ferrothiocyanate. Anal Biochem. 1980;104:10–14. doi: 10.1016/0003-2697(80)90269-9. [DOI] [PubMed] [Google Scholar]
  46. Tan L.A., Yu B., Sim F.C., Kishore U., Sim R.B. Complement activation by phospholipids: the interplay of factor H and C1q. Protein Cell. 2010;1:1033–1049. doi: 10.1007/s13238-010-0125-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. van den Berg R.H., Faber-Krol M.C., van de Klundert J.A., van Es L.A., Daha M.R. Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein. J Immunol. 1996;156:4466–4473. [PubMed] [Google Scholar]
  48. Weiler J.M., Daha M.R., Austen K.F., Fearon D.T. Control of the amplification convertase of complement by the plasma protein β1H. Proc Natl Acad Sci U S A. 1976;73:3268–3272. doi: 10.1073/pnas.73.9.3268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Whaley K., Ruddy S. Modulation of the alternative complement pathways by β1H globulin. J Exp Med. 1976;144:1147–1163. doi: 10.1084/jem.144.5.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Ying S.C., Gewurz A.T., Jiang H., Gewurz H. Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14–26 and 76–92 of the A chain collagen-like region of C1q. J Immunol. 1993;150:169–176. [PubMed] [Google Scholar]
  51. Zipfel P.F., Würzner R., Skerka C. Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol Immunol. 2007;44:3850–3857. doi: 10.1016/j.molimm.2007.06.149. [DOI] [PubMed] [Google Scholar]
  52. Zohair A., Chesne S., Wade R.H., Colomb M.G. Interaction between complement subcomponent C1q and bacterial lipopolysaccharides. Biochem J. 1989;257:865–873. doi: 10.1042/bj2570865. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Protein & Cell are provided here courtesy of Oxford University Press

RESOURCES